These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 11932714)

  • 21. Neoadjuvant therapy for gastrointestinal stromal tumor (GIST): racing against resistance.
    Gold JS; Dematteo RP
    Ann Surg Oncol; 2007 Apr; 14(4):1247-8. PubMed ID: 17265116
    [No Abstract]   [Full Text] [Related]  

  • 22. Dermatofibrosarcoma protuberans: a partial response to imatinib therapy.
    Mehrany K; Swanson NA; Heinrich MC; Weenig RH; Lee KK; White CR; Devere TS
    Dermatol Surg; 2006 Mar; 32(3):456-9. PubMed ID: 16640697
    [No Abstract]   [Full Text] [Related]  

  • 23. Neo-adjuvant STI571 therapy for high-risk gastrointestinal stromal tumour.
    Liu CL; Huang MJ; Lin SC; Chang KM; Tzen CY
    ANZ J Surg; 2004 Apr; 74(4):289-90. PubMed ID: 15043750
    [No Abstract]   [Full Text] [Related]  

  • 24. Case 3. Resection of originally inoperable liver metastases of gastrointestinal stromal tumor after imatinib mesylate therapy.
    Láng I; Hitre E; Horváth Z; Godény M
    J Clin Oncol; 2003 Sep; 21(18):3538-40. PubMed ID: 12972533
    [No Abstract]   [Full Text] [Related]  

  • 25. Imatinib in patients with metastatic gastrointestinal stromal tumours relapsing after hepatic transplantation.
    Bompas E; Boillot O; Bringuier PP; Dumortier J; Blay JY
    Eur J Cancer; 2004 Jun; 40(9):1456-7. PubMed ID: 15177508
    [No Abstract]   [Full Text] [Related]  

  • 26. Imatinib mesylate in the treatment of a large unresectable dermatofibrosarcoma protuberans: a case study.
    Savoia P; Ortoncelli M; Quaglino P; Bernengo MG
    Dermatol Surg; 2006 Aug; 32(8):1097-102. PubMed ID: 16918576
    [No Abstract]   [Full Text] [Related]  

  • 27. Is KIT an important therapeutic target in small cell lung cancer?
    Heinrich MC
    Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5825-8. PubMed ID: 14676102
    [No Abstract]   [Full Text] [Related]  

  • 28. Diabetes research. Researchers puzzle over possible effect of Gleevec.
    Couzin J
    Science; 2005 Mar; 307(5716):1711. PubMed ID: 15774738
    [No Abstract]   [Full Text] [Related]  

  • 29. Locally advanced GISTs need aggressive therapy pending the results of trials.
    Date RS; Mughal MM
    Ann Surg Oncol; 2008 May; 15(5):1540-1; author reply 1542-3. PubMed ID: 18058180
    [No Abstract]   [Full Text] [Related]  

  • 30. Update on the use of imatinib mesylate.
    Sawyers CL
    Clin Adv Hematol Oncol; 2005 Oct; 3(10):757-8. PubMed ID: 16258483
    [No Abstract]   [Full Text] [Related]  

  • 31. Antituberculosis therapy and imatinib for chronic myeloid leukemia.
    Sorà F; De Matteis S; Di Mario A; Maiuro G; Laurenti L; Chiusolo P; Ardito F; Leone G; Sica S
    Clin Infect Dis; 2006 Nov; 43(9):1224. PubMed ID: 17029152
    [No Abstract]   [Full Text] [Related]  

  • 32. Central nervous system metastases from imatinib mesylate resistant gastrointestinal stromal tumor.
    Gerin F; Baloglu O; Morgan JA; Kesari S
    J Neurooncol; 2007 Apr; 82(2):227-8. PubMed ID: 17106648
    [No Abstract]   [Full Text] [Related]  

  • 33. [c-kit: an irresistible ascension from diagnostic marker to therapeutic].
    Scoazec JY
    Ann Pathol; 2002 Jun; 22(3):173-5. PubMed ID: 12410099
    [No Abstract]   [Full Text] [Related]  

  • 34. Cancer drug effective in RA.
    Duke Med Health News; 2006 Dec; 12(12):2. PubMed ID: 17294533
    [No Abstract]   [Full Text] [Related]  

  • 35. [Gastrointestinal stromal tumors: a new model for target therapy].
    Tonini G; Vincenzi B; La Cesa A
    Clin Ter; 2003; 154(2):75-6. PubMed ID: 12856363
    [No Abstract]   [Full Text] [Related]  

  • 36. St. John's wort reduces effectiveness of anticancer medication.
    Health News; 2005 Feb; 11(2):13. PubMed ID: 15732155
    [No Abstract]   [Full Text] [Related]  

  • 37. FDA approves Gleevec for pediatric leukemia.
    FDA Consum; 2003; 37(4):6. PubMed ID: 12971334
    [No Abstract]   [Full Text] [Related]  

  • 38. Should adjuvant imatinib be used as primary treatment for gastrointestinal stromal tumors?
    Hohenberger P
    Nat Clin Pract Oncol; 2008 May; 5(5):240-1. PubMed ID: 18349856
    [No Abstract]   [Full Text] [Related]  

  • 39. PDGFR inhibition in brain tumours--oft expectation fails where most it promises.
    Raymond E
    Eur J Cancer; 2009 Sep; 45(13):2236-8. PubMed ID: 19540747
    [No Abstract]   [Full Text] [Related]  

  • 40. [Targeted therapy with imatinib has reformed the treatment of chronic myeloid leukemia].
    Nielsen JL
    Ugeskr Laeger; 2003 May; 165(20):2111. PubMed ID: 12812107
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.